Related Experiment Video
Updated: Aug 7, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Enabling fully automated insulin delivery through meal detection and size estimation using Artificial Intelligence
Clara Mosquera-Lopez1, Leah M Wilson2, Joseph El Youssef2
1Artificial Intelligence for Medical Systems (AIMS) Lab, Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA. mosquera@ohsu.edu.
The robust artificial pancreas (RAP) system uses machine learning for automated meal detection and insulin dosing. RAP significantly reduces time above target glucose levels compared to traditional methods.
Area of Science:
- Biomedical Engineering
- Artificial Intelligence in Medicine
- Diabetes Technology
Background:
- Automated insulin delivery systems aim to improve glucose control in diabetes management.
- Accurate meal detection and carbohydrate estimation are crucial for effective mealtime insulin dosing.
- Current systems often require manual input, posing a challenge for real-world application.
Purpose of the Study:
- To evaluate the performance of a novel robust artificial pancreas (RAP) system.
- To compare postprandial glucose control between the RAP system and a hybrid model predictive control (MPC) algorithm.
- To assess the efficacy of RAP's automated meal detection and insulin dosing capabilities.
Main Methods:
- A randomized, single-center crossover trial was conducted.
- Participants used both the RAP system and a hybrid MPC algorithm for postprandial glucose control.
- The RAP system incorporates a neural network for automated meal detection and carbohydrate estimation.
- Performance was evaluated over four hours following unannounced meals.
Main Results:
- The RAP system's meal detection algorithm achieved 83.3% sensitivity and a 16.6% false discovery rate with a mean detection time of 25.9 minutes.
- No significant difference in incremental area under the glucose curve was observed between RAP and MPC.
- RAP significantly reduced time above range (glucose >180 mg/dL) by 10.8% (P=0.04).
- RAP showed a trend towards increasing time in range (70-180 mg/dL) by 9.1%.
Conclusions:
- The robust artificial pancreas (RAP) system demonstrates improved glucose control by reducing hyperglycemia.
- Automated meal detection and dosing in RAP enhance usability and potentially improve diabetes management.
- Further research is warranted to optimize RAP performance and explore its long-term benefits.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

